<DOC>
	<DOCNO>NCT00220415</DOCNO>
	<brief_summary>Male female patient 16 70 year age diagnose epilepsy partial seizure take 3 medication medical condition take part research study approximately 80 different location Australia Europe . The purpose study evaluate effectiveness , safety tolerability consistent dosage study drug ( lacosamide ) take orally twice day 4 month . Each patient qualify choose participate study receive placebo ( inactive drug ) gradually increase dos lacosamide ( SPM 927 ) target dose 200mg/day 400mg/day . The target dose placebo maintain 12 week . The study clinic visit include medical history physical exam , ECG , blood urine sample collection , completion seizure diary . Patients complete study may enroll extension trial receive active study drug .</brief_summary>
	<brief_title>A Multicenter , Double-blind , Randomized , Placebo-controlled , Parallel Group Trial Investigate Efficacy Safety SPM 927 ( 200mg/Day 400mg/Day ) Adjunctive Therapy Subjects With Partial Seizures With Without Secondary Generalization</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<criteria>partial seizure without secondary generalization subject receive SPM 927 previous trial</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>